6505--Dutasteride Capsules

Closed Solicitation Posted

Solicitation number
36E79726R0029
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center seeks a single-award contract for Dutasteride Capsules in 0.5MG formulations, with proposals due July 17, 2026, at 2:30 PM Central Daylight Time. A second amendment, issued July 13, extended the deadline from July 14.

Estimated annual usage is 3,912 bottles of 30-count packaging and 25,502 bottles of 90-count packaging. The contract includes a one-year base period and four one-year option periods. Implementation extends up to 60 days from award (or until December 22, 2026, if awarded after October 23).

Products will be distributed through VA and DoD Pharmaceutical Prime Vendor programs to VA facilities, DoD ordering activities, Indian Health Service facilities, Bureau of Prisons facilities, Federal Health Care Centers, and participating State Veteran Homes. Offerors must submit pricing for the base year and all option periods, with a mandatory 0.5% Cost Recovery Fee included. For covered drugs under 38 U.S.C. 8126, prices cannot exceed the Federal Ceiling Price plus the 0.5% Cost Recovery Fee.

Offerors must provide unique 11-digit National Drug Codes specific to their company, submit evidence of FDA approval (NDA, ANDA, or BLA), and demonstrate current acceptable cGMP status for all manufacturing, packaging, and processing facilities. Unit-of-use packaging must use 120cc minimum volume bottles with safety caps, cylindrical bodies with minimum 5.75-inch circumference, and labels fitting 5.25" x 2" dimensions. All products require GS1-128 or HIBCC bar code labeling in linear format at Grade C or better quality. Manufacturers must comply with Drug Supply Chain Security Act requirements. Non-manufacturers must provide a Letter of Commitment from their manufacturer. Contractors must establish agreements with PPVs and submit quarterly sales reports within 30 days of quarter-end.

NAICS code is 325412, Pharmaceutical Preparation Manufacturing. PSC code is 6505, Drugs and Biologicals. Offerors must acknowledge receipt of the amendment prior to the deadline.

Notice text

3 versions

Update #3 · Latest ·

2nd Amendment to Extend Due Date 36E79726R0029 0002 to 07/17/2026, 2:30 PM CT

Update #2 ·

Amendment issued to extend due date and time for receipt of offers. See amendment for details.

Update #1 ·

N/A

Files

File Type Posted
36E79726R0029 0002.docx DOCX document
36E79726R0029 0001.docx DOCX document
36E79726R0029.docx DOCX document

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
6505--Dutasteride Capsules Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity